Cinzia Pellizzoni
Impact in
- Biomaterials top 5%
- Nanoparticle-Based Drug Delivery
- Pharmacology top 10%
- Treatment of Major Depression
- Pharmacogenetics and Drug Metabolism
Papers in
-
- Cancer therapeutics and mechanisms 3
- Protein Degradation and Inhibitors 2
-
- Pharmacogenetics and Drug Metabolism 4
- Treatment of Major Depression 3
- Co-authors
- Italo Poggesi (11 shared papers)E. Frigerio (6 shared papers)M. Strolin Benedetti (7 shared papers)M. G. Castelli (2 shared papers)R. Spinelli (2 shared papers)Enrico Pesenti (3 shared papers)Daniela Fraier (2 shared papers)Joseph C. Fleishaker (2 shared papers)
- Journals
- Biopharmaceutics & Drug Disposition (3 papers)British Journal of Cancer (2 papers)Chirality (2 papers)Pharmacological Research (2 papers)Expert Opinion on Drug Metabolism & Toxicology (1 paper)
- Partner nations
- ItalyUnited StatesBelgium
In The Last Decade
Cinzia Pellizzoni
18 papers receiving 591 citations
Peers
Comparison fields: 5 of 82
- Biomaterials 194
- Pharmacology 129
- Pharmacology 51
- Oncology 133
- Cellular and Molecular Neuroscience 78
Countries citing papers authored by Cinzia Pellizzoni
This map shows the geographic impact of Cinzia Pellizzoni's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Cinzia Pellizzoni with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Cinzia Pellizzoni more than expected).
Fields of papers citing papers by Cinzia Pellizzoni
This network shows the impact of papers produced by Cinzia Pellizzoni. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Cinzia Pellizzoni. The network helps show where Cinzia Pellizzoni may publish in the future.
Co-authors
The 25 scholars most cited alongside Cinzia Pellizzoni, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2000 | 135 | |
| 2 | 2004 | 92 | |
| 3 | 2002 | 87 | |
| 4 | 1995 | 51 | |
| 5 | 1995 | 47 | |
| 6 | 2011 | 44 | |
| 7 | 1999 | 33 | |
| 8 | 2005 | 24 | |
| 9 | 1999 | 20 | |
| 10 | 1996 | 20 | |
| 11 | Dose escalation study of intravenous estramustine phosphate in combination with Paclitaxel and Carboplatin in patients with advanced prostate cancer. | 2003 | 14 |
| 12 | 1999 | 11 | |
| 13 | 1997 | 11 | |
| 14 | 2000 | 9 | |
| 15 | 1995 | 9 | |
| 16 | 1995 | 4 | |
| 17 | 2023 | 2 | |
| 18 | A PK-PD model for predicting tumor growth inhibition in mice: a useful tool in oncology drug development | 2004 | 1 |
About Cinzia Pellizzoni
Cinzia Pellizzoni is a scholar working on Molecular Biology, Pharmacology, Oncology, Pharmacology and Pediatrics, Perinatology and Child Health, having authored 18 papers that have together received 614 indexed citations. Recurring topics across this work include Pharmacogenetics and Drug Metabolism (4 papers), Pharmacological Effects and Toxicity Studies (3 papers), Cancer therapeutics and mechanisms (3 papers), Anesthesia and Sedative Agents (3 papers), Treatment of Major Depression (3 papers), Cancer Treatment and Pharmacology (2 papers), Computational Drug Discovery Methods (2 papers) and Protein Degradation and Inhibitors (2 papers). The work is most often cited by research in Biomaterials (194 citations), Pharmacology (129 citations), Pharmacology (51 citations), Oncology (133 citations) and Cellular and Molecular Neuroscience (78 citations). Cinzia Pellizzoni has collaborated with scholars based in Italy, United States and Belgium. Frequent co-authors include Italo Poggesi, E. Frigerio, M. Strolin Benedetti, M. G. Castelli, R. Spinelli, Enrico Pesenti, Daniela Fraier, Joseph C. Fleishaker, Francesco Angelucci and Matteo Gigli. Their work appears in journals such as Biopharmaceutics & Drug Disposition, British Journal of Cancer, Chirality, Pharmacological Research and Expert Opinion on Drug Metabolism & Toxicology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.